Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2

Go back to Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2